Literature DB >> 26390869

Left ventricular dysfunction and subclinical atherosclerosis in children with classic congenital adrenal hyperplasia: a single-center study from upper Egypt.

Kotb Abbass Metwalley1,2, Hekma Saad Farghaly3, Tahra Sherief4.   

Abstract

UNLABELLED: Few studies assessed carotid artery intima-media thickness (CA-IMT) and left ventricular (LV) function in children with congenital adrenal hyperplasia (CAH) as compared to adults. This study aimed to assess carotid artery structural changes and myocardial function with CAH. The study included 32 children with classic CAH and 32 healthy children matched for age, gender, pubertal status, and socioeconomic status. Blood levels of high-sensitivity C-reactive protein (hs-CRP) and circulating endothelial cells (CECs) were measured. LV mass (LVM) and function were assessed using conventional echocardiography. Duplex ultrasonography was used to measure CA-IMT. Compared to controls, patients had higher hs-CRP and CEC concentrations (p < 0.001) and increased CA-IMT (p < 0.001), indicating vascular endothelial injury and subclinical atherosclerosis; higher LVM index (LVMI) (p < 0.001), indicating LV hypertrophy; and lower ratio of E/A wave and prolonged mitral deceleration time (DcT) and isovolumic relaxation times (IVRTs) (p < 0.001), indicating LV dysfunction. Abnormalities were marked in uncontrolled children on medical treatment. Testosterone levels were positively correlated with CA-IMT, LVMI, and DcT values.
CONCLUSION: This study indicates that children with CAH and enhanced androgen levels are at increased risk of vascular endothelial injury, subclinical atherosclerosis, and LV dysfunction. These findings highlight early monitoring of children with CAH for cardiovascular abnormalities.

Entities:  

Keywords:  Circulating endothelial cells; Congenital adrenal hyperplasia intima thickness; Left ventricular mass index

Mesh:

Substances:

Year:  2015        PMID: 26390869     DOI: 10.1007/s00431-015-2634-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  39 in total

1.  Circulating endothelial precursors: mystery, reality, and promise.

Authors:  S Rafii
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

2.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

Review 3.  Androgen deficiency and hormone-replacement therapy.

Authors:  Andrea M Isidori; Emanuela A Greco; Antonio Aversa
Journal:  BJU Int       Date:  2005-08       Impact factor: 5.588

4.  Cardiovascular abnormalities and impaired exercise performance in adolescents with congenital adrenal hyperplasia.

Authors:  Alberto M Marra; Nicola Improda; Donatella Capalbo; Andrea Salzano; Michele Arcopinto; Amato De Paulis; Maria Alessio; Andrea Lenzi; Andrea M Isidori; Antonio Cittadini; Mariacarolina Salerno
Journal:  J Clin Endocrinol Metab       Date:  2014-11-18       Impact factor: 5.958

5.  Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications.

Authors:  Evangelia Charmandari; Martina Weise; Stefan R Bornstein; Graeme Eisenhofer; Margaret F Keil; George P Chrousos; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

6.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

Authors:  D S Celermajer; K E Sorensen; V M Gooch; D J Spiegelhalter; O I Miller; I D Sullivan; J K Lloyd; J E Deanfield
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

Review 7.  Childhood-onset congenital adrenal hyperplasia: long-term outcome and optimization of therapy.

Authors:  J I Labarta; E Bello; M Ruiz-Echarri; C Rueda; P Martul; E Mayayo; A Ferrández Longás
Journal:  J Pediatr Endocrinol Metab       Date:  2004-03       Impact factor: 1.634

Review 8.  Management of the child with congenital adrenal hyperplasia.

Authors:  Peter C Hindmarsh
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-04       Impact factor: 4.690

Review 9.  Hormonal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  A Bachelot; Z Chakhtoura; A Rouxel; J Dulon; P Touraine
Journal:  Ann Endocrinol (Paris)       Date:  2007-08-08       Impact factor: 2.478

10.  Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials.

Authors:  Lin Xu; Guy Freeman; Benjamin J Cowling; C Mary Schooling
Journal:  BMC Med       Date:  2013-04-18       Impact factor: 8.775

View more
  4 in total

1.  Obtaining accurate measurement of carotid intima-media thickness in children with classic congenital adrenal hyperplasia.

Authors:  Fuat Ozkan; Deniz Ozel; Betul Duran Ozel
Journal:  Eur J Pediatr       Date:  2015-12-10       Impact factor: 3.183

2.  Assessment of cardiac function in children with congenital adrenal hyperplasia: a case control study in Cameroon.

Authors:  J Tony Nengom; S Sap Ngo Um; D Chelo; R Mbono Betoko; J Boombhi; F Mouafo Tambo; A Chiabi; S Kingue; P Koki Ndombo
Journal:  BMC Pediatr       Date:  2017-04-20       Impact factor: 2.125

Review 3.  Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia.

Authors:  Mattia Barbot; Pierluigi Mazzeo; Martina Lazzara; Filippo Ceccato; Carla Scaroni
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-01       Impact factor: 6.055

4.  The relationship of carotid intima-media thickness with anthropometric and metabolic parameters in patients with classic congenital adrenal hyperplasia

Authors:  Hale Tuhan; Tülay Öztürk; Gönül Çatlı; Sezer Acar; Ayhan Abacı; Tuğba Egeli; Korcan Demir; Şule Can; Handan Güleryüz; Bumin Dündar; Ece Böber
Journal:  Turk J Med Sci       Date:  2021-08-30       Impact factor: 0.973

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.